Cara Therapeutics
在场
高管
查看带有其 12 名主要高管的组织结构图
Cara Therapeutics 搜索最多的简介
- Christopher Posner, Director, President and Chief Executive Officer
- Susan Shiff, Director
- Jeffrey Ives, Director
高管在Cara Therapeutics变化
- Helen Boudreau已作为Director加入公司 (新闻发布的2023八月4号).
创建提醒
跟踪 Cara Therapeutics 的高管变动
健康
Cara Therapeutics 拥有 1,818 家竞争者，其中包括 Siemens Healthineers (德国)、IQVIA (美国(美洲)) 和 Saint Francis Health System (美国(美洲))。
Popular M&A news in 健康
- Xaira Therapeutics 凭借他的 1,000 百万美元筹款活动成为了独角兽。 (公布2024四月25号).
- Two Chairs 刚刚宣布为 72 筹款数百万美元。 (公布2024四月18号).
- Grow Therapy 刚刚宣布为 88 筹款数百万美元。 (公布2024四月12号).
健康 行业的其他推荐联系人
消息
Cara Therapeutics 的最新新闻稿
- Cara Therapeutics to Present at the Canaccord Genuity 42nd Annual Growth Conference | Cara Therapeutics
- Cara Therapeutics to Announce Second Quarter 2022 Financial Results on August 8, 2022 | Cara Therapeutics
- Cara Therapeutics Announces Positive Topline Results from KOMFORT Phase 2 Trial of Oral Difelikefalin for the Treatment of Pruritus in Patients with Notalgia Paresthetica | Cara Therapeutics
- Cara Therapeutics to Present at Upcoming Investor Conferences | Cara Therapeutics
- Cara Therapeutics Reports First Quarter 2022 Financial Results | Cara Therapeutics
- Cara Therapeutics to Present at May Investor Conferences | Cara Therapeutics
- Cara Therapeutics to Announce First Quarter 2022 Financial Results on May 9, 2022 | Cara Therapeutics
- Press Releases | Cara Therapeutics
- Kapruvia® approved by European Commission for the treatment of moderate-to-severe pruritus in hemodialysis patients | Cara Therapeutics
- Press Releases | Cara Therapeutics
- View more press releases Close
通过电子邮件
